← Back to Search

Yoga & Meditation for Irritable Bowel Syndrome

N/A
Recruiting
Led By Alla Kushnir, MD
Research Sponsored by The Cooper Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre intervention to 6 weeks after intervention (at completion of intervention which lasts 6 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if yoga & meditation can reduce anxiety & improve quality of life in kids w/ IBS. It's a 6-week, twice-weekly program.

Who is the study for?
This trial is for adolescents aged 12-21 with any type of Irritable Bowel Syndrome (IBS) who are patients at Cooper Pediatric Gastroenterology in Voorhees or Camden, NJ. They must be able to access the internet to watch yoga videos and commit to completing at least 4 out of the 6 modules.
What is being tested?
The study tests a Standardized Yoga & Meditation Program designed for stress reduction in young IBS patients. Over six weeks, participants will follow this program twice weekly at home, aiming to reduce anxiety and improve their quality of life.
What are the potential side effects?
Yoga and meditation are generally considered safe practices with minimal risk. Possible side effects may include muscle soreness or strain from physical postures if not performed correctly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre intervention to 6 weeks after intervention (at completion of intervention which lasts 6 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre intervention to 6 weeks after intervention (at completion of intervention which lasts 6 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety
Children Somatic Symptoms Inventory
Pediatric Quality of Life

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: IBS Patients Doing YogaExperimental Treatment1 Intervention
All patients will fall under the arm of "IBS Patients Doing Yoga" and will follow the yoga videos that are assigned to them during the study. The participants are their own controls and their symptom changes will be recorded pre- and post-video watching and participation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830

Find a Location

Who is running the clinical trial?

The Cooper Health SystemLead Sponsor
80 Previous Clinical Trials
35,517 Total Patients Enrolled
Alla Kushnir, MDPrincipal InvestigatorThe Cooper Health System
1 Previous Clinical Trials
69 Total Patients Enrolled

Media Library

Yoga Clinical Trial Eligibility Overview. Trial Name: NCT05719246 — N/A
Irritable Bowel Syndrome Research Study Groups: IBS Patients Doing Yoga
Irritable Bowel Syndrome Clinical Trial 2023: Yoga Highlights & Side Effects. Trial Name: NCT05719246 — N/A
Yoga 2023 Treatment Timeline for Medical Study. Trial Name: NCT05719246 — N/A
~3 spots leftby Dec 2026